Why Newly Nasdaq-listed Cynapsus Offers Big Upside
Cynapsus Therapeutics Inc. (CYNA) long-awaited U.S. initial public offering is set to close early next week. The company recently announced that it plans to offer 4.5 million shares of common stock at a price of $14.00 per share. Gross proceeds from the offering total $63.0 million. The company has granted to the underwriters (sole book-runner…